US FDA grants priority review to Daiichi Sankyo and AstraZeneca’s sBLA of Enhertu
Enhertu is a HER2-directed Antibody Drug Conjugate (ADC) being jointly developed by Daiichi Sankyo and AstraZeneca for treatment…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Research
IIT Mandi researchers discover phytochemicals in Himalayan plant that inhibit COVID-19 virus
Researchers show that phytochemical-rich petals of Rhododendron arboreum found in the Himalayan region, locally called “Buransh”…
Pfizer’s Prevnar 20 with Pfizer-BioNTech COVID-19 vaccine shows positive results in phase-III study
responses elicited by Prevnar 20 for all 20 serotypes were similar whether given with a dose of the Pfizer-BioNTech COVID-19…
New study shows novel strategy to improve quality checking of generic drugs
The strategy is likely to improve the regulatory and decision-making aspects related to pharmaceutical products
Novartis and Molecular Partners report positive topline data from phase-II study for Ensovibep
The secondary endpoint of hospitalisation and/or ER visits related to COVID-19, or death showed an overall 78 per cent reduction…
AbbVie submits applications for Upadacitinib in to US FDA and EMA
In the trial study, evaluating the efficacy and safety of Upadacitinib in adult patients with nr-axSpA, Upadacitinib met its…
Maharashtra health minister inaugurates BSV R&D centre at Airoli
The R&D centre will endeavour to bring scientifically-advanced biological, biotechnology products and novel drug delivery…
Leiden University Medica Center and Intravacc to start clinical trial with new intranasal corona…
Nasal spray vaccine based on soluble nano-spheres with synthetic corona proteins
Kintor Pharma announces first patient dosing of phase-III clinical trial of Pyrilutamide to treat…
On 24th November, 2021, Kintor Pharma announced that China's National Medical Products Administration (NMPA) greenlighted the…
Researchers at Technical University of Munich investigate mRNA nanoparticles
Researchers at the Heinz Maier-Leibnitz Zentrum (MLZ) used the high neutron flux available in Garching to characterise various…
Covaxin demonstrates robust safety and immunogenicity in two-to-18 year old: Study
Bharat Biotech had conducted phase-II/III, open-label and multi-centre studies to evaluate the safety, reactogenicity and…
Russian drug Avifavir effective against corona virus variants: ChemRar Group
The drug affects the highly conservative and mutation-resistant replication systems of RNA virus (RdRp) via three complementary…
China CanSinoBIO’s vaccine 57.5 per cent effective against COVID in phase-III trial: Study
The single-shot Ad5-nCoV vaccine, which CanSinoBIO co-developed with the Chinese military-backed Beijing Institute of…
Biocon Biologics initiates clinical study for Itolizumab in Lupus Nephritis
Equalise is a phase-Ib open-label, proof-of-concept clinical study currently studying Lupus Nephritis patients in the Part B…
University of Oxford study supports use of Vaxzevria as third-dose booster against Omicron
Neutralising anti-body levels against Omicron following a third-dose boost of Vaxzevria were broadly similar to levels achieved…
Valneva says Chikungunya vaccine phase-III trial has met primary endpoint
In August, after Valneva gave a positive update on the phase-III trial
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant in…
Only antibody authorised in the US for pre-exposure prophylaxis of COVID-19
South Africa begins trial of new oral drug against COVID-19
South Africa has been struggling with its plans to achieve herd immunity through vaccinations, with widespread vaccine hesitancy,…
Zydus receives Orphan Drug Designation from US FDA for malaria treatment
The Orphan Drug Designation provides up to seven years of marketing exclusivity in the US
Scientists develop molecule that blocks COVID-19 infection
The researchers at Aarhus University in Denmark noted that the molecule is cheaper and easier to manufacture than the antibodies…